OPK

Opko Health Inc.

1.17

USD

OPK Earnings Reports

Positive Surprise Ratio

OPK beat 21 of 41 last estimates.

51%

Next Report

Date of Next Report

Apr 28, 2026

Estimate for Q1 26 (Revenue/ EPS)

$131.82M

-$0.07

Implied change from Q4 25 (Revenue/ EPS)

-11.23%

+75.00%

Implied change from Q1 25 (Revenue/ EPS)

-12.06%

-30.00%

Opko Health Inc. earnings per share and revenue

On Feb 26, 2026, OPK reported earnings of -0.04 USD per share (EPS) for Q4 25, beating the estimate of -0.06 USD, resulting in a 42.28% surprise. Revenue reached 148.50 million, compared to an expected 141.15 million, with a 5.20% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).

Looking ahead to Q1 26, 6 analysts forecast an EPS of -0.07 USD, with revenue projected to reach 131.82 million USD, implying an increase of 75.00% EPS, and decrease of -11.23% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Alpha Tau Medical Ltd. Ordinary Shares

Report Date

Mar 09, 2026 For Q4 25

Estimate

-$0.12

Actual

-$0.08

Surprise

+36.51%

ClearPoint Neuro, Inc. Common Stock

Report Date

Mar 17, 2026 For Q4 25

Estimate

-$0.20

Actual

-$0.27

Surprise

-32.35%

Stereotaxis, Inc. Common Stock

Report Date

Mar 09, 2026 For Q4 25

Estimate

-$0.06

Actual

-$0.06

Surprise

+10.04%

Rapid Micro Biosystems, Inc. Class A Common Stock

Report Date

Mar 12, 2026 For Q4 25

Estimate

-$0.22

Actual

-$0.28

Surprise

-23.35%

Hyperfine, Inc. Class A Common Stock

Report Date

Mar 18, 2026 For Q4 25

Estimate

-$0.08

Actual

-$0.08

Surprise

+1.96%

Neuronetics, Inc. Common Stock

Report Date

Mar 17, 2026 For Q4 25

Estimate

-$0.10

Actual

-$0.10

Surprise

+8.09%

InspireMD, Inc.

Report Date

Mar 18, 2026 For Q4 25

Estimate

-$0.19

Actual

-$0.14

Surprise

+29.01%

Tenon Medical, Inc. Common Stock

Report Date

Mar 19, 2026 For Q4 25

Estimate

-$0.36

Actual

-$0.22

Surprise

+40.09%

Nuwellis, Inc. Common Stock

Report Date

Mar 10, 2026 For Q4 25

Estimate

-$1.59

Actual

-$1.50

Surprise

+5.73%

FAQ

What were Opko Health Inc.'s earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Opko Health Inc. reported EPS of -$0.04, beating estimates by 42.28%, and revenue of $148.50M, 5.2% above expectations.

How did the market react to Opko Health Inc.'s Q4 2025 earnings?

The stock price moved -- 0%, changed from $1.20 before the earnings release to $1.20 the day after.

When is Opko Health Inc. expected to report next?

The next earning report is scheduled for Apr 28, 2026.

What are the forecasts for Opko Health Inc.'s next earnings report?

Based on 6 analysts, Opko Health Inc. is expected to report EPS of -$0.07 and revenue of $131.82M for Q1 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.